Biosimilars Focus PPS is a world leading CRO in protein analytics with GMP-compliant characterization for protein therapeutics and supports multiple biosimilar developers, signaling strong cross-selling opportunities into biosimilar programs and regulatory-ready analytics services.

Strategic Merger The 2021 merger with GeneWerk enhances capabilities in protein and gene therapy analytics, creating a broader platform that can be pitched as a one-stop solution for analytics, potentially broadening client base and upsell opportunities.

PANATecs Suite Under the PANATecs brand PPS offers high-grade life-science tools for protein analytics, immunology and cell biology, presenting a complementary product ecosystem that sales teams can cross-sell to research labs and biotech developers.

Mid-market Footprint With 11-50 employees and revenue in the low to mid single digits, PPS sits in a scalable CRO niche ideal for targeted outreach to mid-market biotech startups and growing biopharma firms seeking GMP-compliant analytics without enterprise-level pricing.

Tech Stack Leverage Existing tech stack including Joomla, TYPO3 and analytics tools offers opportunities to position PPS as a modern, cost-efficient partner for digital marketing, client portals, and streamlined project management to improve bid win rates.